| アブストラクト | Pharmacovigilance aims to identify adverse drug reactions using postmarket surveillance data under real-world conditions of use. Unlike passive pharmacovigilance, which is based on largely voluntary (and hence incomplete) spontaneous reports of adverse drug reactions with limited information on patient characteristics, active pharmacovigilance is based on electronic health records containing detailed information about patient populations, thereby allowing consideration of modifying factors such as polypharmacy and comorbidity, as well as sociodemographic characteristics. With the present shift toward active pharmacovigilance, statistical methods capable of addressing the complexities of such data are needed. We describe four such methods here, and demonstrate their application in the analysis of a large retrospective cohort of diabetics taking anti-hyperglycemic medications that may increase the risk of adverse cardiovascular events. |
|---|
| ジャーナル名 | Journal of biopharmaceutical statistics |
|---|
| Pubmed追加日 | 2014/4/5 |
|---|
| 投稿者 | Zhuo, Lan; Farrell, Patrick J; McNair, Doug; Krewski, Daniel |
|---|
| 組織名 | a School of Mathematics and Statistics , Carleton University , Ottawa , Ontario ,;Canada. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/24697529/ |
|---|
